1. Cives M, Strosberg J. Gastroenteropancreatic neuroendocrine tumors. CA Cancer J Clin. 2018;68(6):471–87.
2. • Dasari A, Shen C, Halperin D, Zhao B, Zhou S, Xu Y, et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol. 2017;3(10):1335–42 This work represents the most updated picture of the epidemiology of neuroendocrine tumors.
3. •• Lloyd RV, Osamura RY, Kloppel G, Rosai J, editors. WHO Classification of tumours of endocrine organs. WHO/IARC Classification of Tumours, vol. 10. 4th ed. Lyon: IARC Press; 2017. This is the most recent pathologic classification of pancreatic neuroendocrine tumors (panNETs). The clinical management of panNETs must take into account information from this classification.
4. Bosman TF, Carneiro F, Hruban RH, Theise ND, editors. Nomenclature and classification of neuroendocrine neoplasms of the digestive system. WHO classification of tumours of the digestive system. Lyon: IARC Press; 2010.
5. Travis W, Brambilla E, Muller-Hermelink H, et al. World Health Organization classification of tumours. Pathology and genetics of tumours of the lung, pleura, thymus and heart. Lyon: IARC Press; 2004.